[Hiring] Director, Launch Excellence @Revolution Medicines

Role Description

This is a unique opportunity to play a critical role in advancing Revolution Medicines' commercialization strategy during a period of significant growth. We are seeking an experienced and highly collaborative Director, Launch Project Manager to lead in one of the company's key Disease Areas by driving cross-functional planning, alignment, and execution across global commercialization priorities.

This role sits within the Commercialization Effectiveness & Operations (CE&O) function and reports to the Executive Director, Global Commercialization Effectiveness.

In partnership with Global Commercial, Medical, Market Access, and cross-functional leaders, you will serve as the primary project management partner to the Global Commercialization Team, the Global Commercial Team and other cross-functional teams in your assigned Disease Area.

Operating in a build-while-scaling environment, you will bring clarity, structure, and execution discipline to complex cross-functional initiatives while helping strengthen commercialization ways of working. As the capability matures, this role may expand to include people leadership responsibilities.

What You’ll Do

• Lead project management support for Global Commercialization Teams and Global Commercial Teams within an assigned Disease Area, driving alignment, accountability, and execution across strategic priorities.
• Drive execution of global commercial and commercialization initiatives, ensuring milestones, risks, dependencies, and key decisions are effectively managed.
• Coordinate and integrate inputs across Commercial, Medical, Market Access, Regulatory, Supply, Legal, Finance, and regional stakeholders into cohesive commercialization plans.
• Facilitate planning, governance, and decision-making processes, ensuring effective follow-through on actions and commitments.
• Identify and proactively manage risks, dependencies, and execution challenges, escalating issues as appropriate.
• Develop and maintain project plans, dashboards, timelines, and reporting tools that provide visibility into progress and priorities.
• Support launch readiness and other key commercialization initiatives within the Disease Area.
• Partner closely with Project Management colleagues across the organization to ensure alignment between development, life cycle, medical, market access and commercial plans and deliverables.
• Contribute to the development of Commercial Project Management capabilities, including tools, templates, best practices, and ways of working.

Qualifications

• Bachelor’s degree, with 10+ years of relevant experience in biotech/pharma/healthcare.
• Significant experience leading complex, cross‑functional projects or commercialization initiatives.
• Experience supporting global commercial organizations, including launch readiness, lifecycle management, or major commercialization initiatives.
• Experience working across global and regional operating models.
• Strong project management skills, including planning, dependency management, risk management, stakeholder leadership, and executive communication.
• Proven ability to influence without authority and drive alignment across diverse stakeholder groups.
• Experience partnering with senior commercial, medical affairs, market access, and cross-functional leaders.
• Track record of thriving in fast-paced, evolving environments with a proactive, solutions-oriented mindset.
• Excellent communication, facilitation, and interpersonal skills, with the ability to translate complexity into clarity for diverse audiences.
• Strong judgment, organizational skills, and attention to detail.

Preferred Skills

• Advanced degree (MBA/MS/PhD).
• Oncology / specialty pharma commercialization experience.
• Formal Project Management training or certification (e.g., PMP).
• Experience supporting multiple concurrent programs or portfolios.
• Early people leadership experience or readiness to step into people leadership as the capability scales.

Benefits

• Competitive cash compensation.
• Robust equity awards.
• Strong benefits.
• Significant learning and development opportunities.

Company Description

Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.

Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.